Sec Form 13G Filing - Blue Owl Capital Holdings LP filing for Context Therapeutics Inc. (CNTX) - 2025-02-14

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  The reported percentage is calculated based on 74,998,312 shares of common stock outstanding as of November 4, 2025, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2025.


SCHEDULE 13G


 
Blue Owl Capital Holdings LP
 
Signature:/s/ Karen Hager
Name/Title:Karen Hager/Chief Compliance Officer
Date:02/14/2025
primary_doc.xml